Cellegy Pharmaceuticals (CLGY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cellegy Pharmaceuticals (CLGY)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Hoffman who wrote (196)	9/21/1999 1:40:00 PM
From: Arthur Radley	of 322

From theStreet.com today..... "Cellegy (CLGY:Nasdaq) was a dog for years. Worse, it works on diseases that no one likes to hear about. Seriously, investors pass on this company solely because of that. Try explaining that to the efficient market blowhards. Cellegy is working on a nitroglycerin gel, Anogesic, for anal fissures. The drug is finished with Phase III and the results should be out shortly. If they're positive, the drug could sell several hundred million annually, say people at two hedge funds that own this $90 million market cap company

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next